0
     

Report Added
Report already added
Legionella Testing Market by Test Type (Culture, Urinary Antigen Test, DFA, PCR), Application (Water & IVD Testing (Urine, Blood)), End User (Hospitals, Clinics, Diagnostic Labs, Water Treatment Industries), Region - Global Forecast to 2027

Legionella Testing Market by Test Type (Culture, Urinary Antigen Test, DFA, PCR), Application (Water & IVD Testing (Urine, Blood)), End User (Hospitals, Clinics, Diagnostic Labs, Water Treatment Industries), Region - Global Forecast to 2027

The global legionella testing market is projected to reach USD 439 million by 2027 from USD 296 million in 2022, at a CAGR of 8.2% during the forecast period. Growth in this market is mainly driven by the rising geriatric population coupled with increasing prevalence of legionella-related illness, and rising demand for rapid diagnostics.

"The PCR segment accounted for the highest growth rate in the legionella testing market, by test type, during the forecast period."

The legionella testing market is segmented into culture methods, urinary antigen tests, direct fluorescent antibody tests, and PCR based on product. In 2021, the PCR segment accounted for the highest growth rate in the legionella testing market. Market growth can largely be attributed to its speed, versatility, and simplicity.

"Water & Other Industries segment accounted for the highest CAGR."
Based on the end user, the legionella testing market has been segmented into hospitals, diagnostic laboratories, water & other industries, and other end user. In 2021, the water & other industries segment accounted for the highest growth rate. This can be attributed to the rising population and urbanization, and the increased demand for new water resources
"Asia Pacific: The fastest-growing region legionella testing market."

The global legionella testing market is segmented into North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. The Asia Pacific region is projected to register the highest CAGR during the forecast period. Factors such as government efforts to increase awareness about the early disease diagnosis and regular health check-ups

The primary interviews conducted for this report can be categorized as follows:
•By Company Type: Tier 1 - 40%, Tier 2 - 30%, and Tier 3 -30%
•By Designation: C-level - 27%, D-level - 18%, and Others - 55%
•By Region: North America -51%, Europe - 21%, Asia Pacific - 18%, Latin America – 6%, and the Middle East & Africa – 4%

Lists of Companies Profiled in the Report:
•Thermo Fisher Scientific, Inc. (US)
•Merck KGaA (Germany)
•Bio-Rad Laboratories, Inc. (US)
•IDEXX Laboratories, Inc. (US)
•bioMérieux S.A. (France)
•Becton, Dickinson, and Company (US)
•Alere, Inc. (US)
•Eurofins Scientific (Luxembourg)
•Roche Diagnostics (Switzerland)
•Pall Corporation (Danaher) (US)
•Quidel Corporation (US)
•Eiken Chemical Co., Ltd. (Japan)
•Hologic, Inc. (US)
•QIAGEN (Germany)
•Takara Bio, Inc. (Japan)
•Environmental Safety Technologies, Inc. (US)
•Hydrosense (Scotland)
•Accepta Ltd. (UK)
•LuminUltra Technologies Ltd. (Canada)
•Pro-Lab Diagnostics, Inc. (Canada)
•BioAlert Solutions (Canada)
•Pacific Water Technology (Australia)
•Aquacert Ltd. (UK)
•DTK Water (UK)
•Sens Solutions (Spain)
•Genomadix, Inc. (US)
•Phigenics, LLC (US).

Research coverage:
This report provides a detailed picture of the global legionella testingmarket. It aims at estimating the size and future growth potential of the market across different segments, such as test type, application, end user, and region. The report also includes an in-depth competitive analysis of the key market player, along with their company profiles, recent developments, and key market strategies.

Key benefits of buying the report
:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall legionella testing market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.

Table of Content

1INTRODUCTION27
1.1STUDY OBJECTIVES27
1.2MARKET DEFINITION27
TABLE 1INCLUSIONS AND EXCLUSIONS27
1.3STUDY SCOPE28
1.4YEARS CONSIDERED28
1.5CURRENCY CONSIDERED29
1.6LIMITATIONS29
1.7STAKEHOLDERS29
2RESEARCH METHODOLOGY30
2.1RESEARCH DATA30
FIGURE 1LEGIONELLA TESTING MARKET: RESEARCH DESIGN METHODOLOGY30
2.1.1SECONDARY DATA31
2.1.1.1Key data from secondary sources31
2.1.2PRIMARY DATA32
2.1.2.1Key data from primary sources33
TABLE 2KEY DATA FROM PRIMARY SOURCES33
FIGURE 2KEY INDUSTRY INSIGHTS34
2.1.2.2Breakdown of primary interviews34
FIGURE 3BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS (LEGIONELLA TESTING MARKET)34
FIGURE 4BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION35
2.2MARKET SIZE ESTIMATION35
2.2.1BOTTOM-UP APPROACH36
2.2.1.1Approach 1: Company revenue estimation approach36
FIGURE 5BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION APPROACH36
2.2.1.2Approach 2: Presentations of companies and primary interviews36
2.2.1.3Growth forecast37
2.2.1.4CAGR projections37
FIGURE 6CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS37
2.2.2TOP-DOWN APPROACH38
FIGURE 7LEGIONELLA TESTING MARKET: TOP-DOWN APPROACH38
2.3DATA TRIANGULATION39
FIGURE 8DATA TRIANGULATION METHODOLOGY39
2.4RESEARCH ASSUMPTIONS40
2.5LIMITATIONS AND RISK ASSESSMENT40
FIGURE 9LIMITATIONS: LEGIONELLA TESTING MARKET40
TABLE 3RISK ASSESSMENT: LEGIONELLA TESTING MARKET41
3EXECUTIVE SUMMARY42
FIGURE 10LEGIONELLA TESTING MARKET, BY TEST TYPE, 2022 VS. 2027 (USD MILLION)42
FIGURE 11LEGIONELLA TESTING MARKET, BY APPLICATION, 2022 VS. 2027 (USD MILLION)43
FIGURE 12LEGIONELLA TESTING MARKET, BY END USER, 2022 VS. 2027 (USD MILLION)43
FIGURE 13LEGIONELLA TESTING MARKET, BY REGION, 2022 VS. 2027 (USD MILLION)44
4PREMIUM INSIGHTS45
4.1LEGIONELLA TESTING MARKET OVERVIEW45
FIGURE 14GROWING PREVALENCE OF LEGIONELLA-RELATED ILLNESS AND RISING GERIATRIC POPULATION TO DRIVE MARKET GROWTH45
4.2LEGIONELLA TESTING MARKET SHARE, BY TEST TYPE, 2022 VS. 202746
FIGURE 15PCR SEGMENT WILL CONTINUE TO DOMINATE MARKET IN 202746
4.3LEGIONELLA TESTING MARKET SHARE, BY APPLICATION, 2022 VS. 202746
FIGURE 16WATER TESTING SEGMENT TO HOLD LARGEST MARKET SHARE46
4.4LEGIONELLA TESTING MARKET SHARE, BY END USER, 2022 VS. 202747
FIGURE 17WATER & OTHER INDUSTRIES TO CONTINUE TO DOMINATE MARKET IN 202747
4.5LEGIONELLA TESTING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES47
FIGURE 18ASIA PACIFIC TO REGISTER HIGHEST GROWTH RATE47
5MARKET OVERVIEW48
5.1INTRODUCTION48
5.2MARKET DYNAMICS48
FIGURE 19LEGIONELLA TESTING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES48
5.2.1DRIVERS49
5.2.1.1Rising incidence of pneumonia and legionella-related illnesses49
5.2.1.2Increasing demand for rapid advanced diagnostic technologies49
5.2.1.3Technological advancements in bacterial testing49
5.2.1.4Stringent regulations for regular water testing50
5.2.2RESTRAINTS51
5.2.2.1Lack of reimbursement policies51
5.2.3OPPORTUNITIES51
5.2.3.1Opportunities in growing economies51
5.2.3.2Legal requirements for water testing51
5.2.4CHALLENGES52
5.2.4.1Difficulties in detection52
5.2.4.2Limited awareness in underdeveloped countries52
5.2.4.3High health costs associated with Legionella53
5.3PRICING ANALYSIS53
TABLE 4AVERAGE SELLING PRICE OF LEGIONELLA TESTING PRODUCTS (2022)53
5.4PATENT ANALYSIS54
FIGURE 20PATENT ANALYSIS FOR MOTORIZED LEGIONELLA TESTING DEVICES54
TABLE 5LIST OF KEY PATENTS55
5.5VALUE CHAIN ANALYSIS57
FIGURE 21VALUE CHAIN ANALYSIS: MAJOR VALUE IS ADDED DURING MANUFACTURING AND ASSEMBLY PHASES57
5.6SUPPLY CHAIN ANALYSIS58
FIGURE 22LEGIONELLA TESTING MARKET: SUPPLY CHAIN ANALYSIS58
5.7ECOSYSTEM/MARKET MAP59
FIGURE 23LEGIONELLA TESTING MARKET: ECOSYSTEM/MARKET MAP59
TABLE 6LEGIONELLA TESTING MARKET: ROLE IN ECOSYSTEM60
5.8PORTER’S FIVE FORCES ANALYSIS60
TABLE 7LEGIONELLA TESTING MARKET: PORTER’S FIVE FORCES ANALYSIS60
5.8.1THREAT OF NEW ENTRANTS61
5.8.2THREAT OF SUBSTITUTES61
5.8.3BARGAINING POWER OF BUYERS61
5.8.4BARGAINING POWER OF SUPPLIERS61
5.8.5DEGREE OF COMPETITION61
5.9PESTEL ANALYSIS62
5.9.1POLITICAL FACTORS62
5.9.2ECONOMIC FACTORS62
5.9.3SOCIAL FACTORS62
5.9.4TECHNOLOGICAL FACTORS63
5.9.5ENVIRONMENTAL FACTORS63
5.9.6LEGAL FACTORS63
5.10REGULATORY LANDSCAPE64
TABLE 8NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS64
TABLE 9EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS65
TABLE 10ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS65
TABLE 11LATIN AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS66
TABLE 12REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS66
5.10.1NORTH AMERICA66
5.10.1.1US66
5.10.1.2Canada67
5.10.2EUROPE67
5.10.3ASIA PACIFIC67
5.10.3.1Japan67
5.10.3.2India67
5.10.4LATIN AMERICA68
5.10.4.1Brazil68
5.10.4.2Mexico68
5.10.5MIDDLE EAST68
5.10.6AFRICA69
5.11TRADE ANALYSIS69
5.11.1TRADE ANALYSIS FOR DIAGNOSTIC AND LABORATORY REAGENTS69
TABLE 13IMPORT DATA FOR DIAGNOSTIC AND LABORATORY REAGENTS, BY COUNTRY, 2017–2021 (USD MILLION)69
TABLE 14EXPORT DATA FOR DIAGNOSTIC AND LABORATORY REAGENTS, BY COUNTRY, 2017–2021 (USD MILLION)69
5.12TECHNOLOGY ANALYSIS70
5.13KEY CONFERENCES & EVENTS IN 2022–202371
TABLE 15LEGIONELLA TESTING MARKET: DETAILED LIST OF CONFERENCES & EVENTS71
5.14TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES72
FIGURE 24REVENUE SHIFT IN THE LEGIONELLA TESTING MARKET72
5.15KEY STAKEHOLDERS & BUYING CRITERIA72
5.15.1KEY STAKEHOLDERS IN BUYING PROCESS72
FIGURE 25INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS OF LEGIONELLA TESTING PRODUCTS72
TABLE 16INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS OF LEGIONELLA TESTING PRODUCTS73
5.15.2BUYING CRITERIA73
FIGURE 26KEY BUYING CRITERIA FOR LEGIONELLA TESTING PRODUCTS73
TABLE 17KEY BUYING CRITERIA FOR LEGIONELLA TESTING PRODUCTS73
5.16CASE STUDIES74
6LEGIONELLA TESTING MARKET, BY TEST TYPE75
6.1INTRODUCTION76
TABLE 18LEGIONELLA TESTING MARKET, BY TEST TYPE, 2020–2027 (USD MILLION)76
6.2PCR76
6.2.1INCREASED USAGE OF PCR TO SUPPORT MARKET GROWTH76
TABLE 19KEY PCR PRODUCTS AVAILABLE IN THE MARKET77
TABLE 20LEGIONELLA TESTING MARKET FOR PCR, BY REGION, 2020–2027 (USD MILLION)77
6.3CULTURE METHODS77
6.3.1HIGHER SPECIFICITY AND SENSITIVITY TO DRIVE MARKET77
TABLE 21KEY CULTURE METHODS AVAILABLE IN THE MARKET78
TABLE 22LEGIONELLA TESTING MARKET FOR CULTURE METHODS, BY REGION, 2020–2027 (USD MILLION)79
6.4URINARY ANTIGEN TESTS79
6.4.1RAPID OUTCOMES TO DRIVE MARKET GROWTH79
TABLE 23KEY URINARY ANTIGEN TESTS AVAILABLE IN THE MARKET79
TABLE 24LEGIONELLA TESTING MARKET FOR URINARY ANTIGEN TESTS, BY REGION, 2020–2027 (USD MILLION)80
6.5DIRECT FLUORESCENT ANTIBODY TESTS80
6.5.1RAPIDITY AND EASE OF USE TO BOOST ADOPTION OF TESTS80
TABLE 25LEGIONELLA TESTING MARKET FOR DIRECT FLUORESCENT ANTIBODY TESTS, BY REGION, 2020–2027 (USD MILLION)80
7LEGIONELLA TESTING MARKET, BY APPLICATION81
7.1INTRODUCTION82
TABLE 26LEGIONELLA TESTING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)82
7.2WATER TESTING82
TABLE 27LEGIONELLA TESTING MARKET FOR WATER TESTING, BY TYPE, 2020–2027 (USD MILLION)83
TABLE 28LEGIONELLA TESTING MARKET FOR WATER TESTING, BY REGION, 2020–2027 (USD MILLION)83
7.2.1PCR83
7.2.1.1Rapid diagnosis to spur segment growth83
TABLE 29WATER TESTING MARKET FOR PCR, BY REGION, 2020–2027 (USD MILLION)84
7.2.2MICROBIAL CULTURE84
7.2.2.1Long incubation periods make isolation difficult, affecting adoption of culture techniques84
TABLE 30WATER TESTING MARKET FOR MICROBIAL CULTURE, BY REGION, 2020–2027 (USD MILLION)85
7.2.3DFA STAIN85
7.2.3.1High test specificity to drive adoption of DFA staining85
TABLE 31WATER TESTING MARKET FOR DFA STAIN, BY REGION, 2020–2027 (USD MILLION)86
7.3IVD TESTING86
TABLE 32LEGIONELLA TESTING MARKET FOR IVD TESTING, BY TYPE, 2020–2027 (USD MILLION)86
TABLE 33LEGIONELLA TESTING MARKET FOR IVD TESTING, BY REGION, 2020–2027 (USD MILLION)87
7.3.1URINE ANTIGEN TESTS87
7.3.1.1Rapid and early diagnosis capabilities to drive market growth87
TABLE 34IVD TESTING MARKET FOR URINE ANTIGEN TESTS, BY REGION, 2020–2027 (USD MILLION)88
7.3.2PCR88
7.3.2.1Emergence of advanced technologies such as qRT-PCR to support market growth88
TABLE 35IVD TESTING MARKET FOR PCR, BY REGION, 2020–2027 (USD MILLION)88
7.3.3BLOOD CULTURE & SPUTUM TESTS89
7.3.3.1Longer incubation period resulting in lower adoption of blood culture techniques89
TABLE 36IVD TESTING MARKET FOR BLOOD CULTURE & SPUTUM TESTS, BY REGION, 2020–2027 (USD MILLION)89
7.3.4DFA STAIN90
7.3.4.1Sensitivity variations affect use of DFA staining in IVD tests90
TABLE 37IVD TESTING MARKET FOR DFA STAIN, BY REGION, 2020–2027 (USD MILLION)90
7.4OTHER APPLICATIONS90
TABLE 38LEGIONELLA TESTING MARKET FOR OTHER APPLICATIONS, BY REGION, 2020–2027 (USD MILLION)91
8LEGIONELLA TESTING MARKET, BY END USER92
8.1INTRODUCTION93
TABLE 39LEGIONELLA TESTING MARKET, BY END USER, 2020–2027 (USD MILLION)93
8.2WATER & OTHER INDUSTRIES93
8.2.1STRINGENT REGULATIONS AND GROWING POPULATION TO DRIVE MARKET GROWTH93
TABLE 40LEGIONELLA TESTING MARKET FOR WATER & OTHER INDUSTRIES, BY REGION, 2020–2027 (USD MILLION)94
8.3DIAGNOSTIC LABORATORIES94
8.3.1HEALTHCARE INFRASTRUCTURE IMPROVEMENTS TO BOOST MARKET GROWTH94
TABLE 41LEGIONELLA TESTING MARKET FOR DIAGNOSTIC LABORATORIES, BY REGION, 2020–2027 (USD MILLION)95
8.4HOSPITALS95
8.4.1INCREASING ADOPTION OF DIAGNOSTIC TOOLS TO SUPPORT MARKET GROWTH95
TABLE 42LEGIONELLA TESTING MARKET FOR HOSPITALS, BY REGION, 2020–2027 (USD MILLION)96
8.5OTHER END USERS96
TABLE 43LEGIONELLA TESTING MARKET FOR OTHER END USERS, BY REGION, 2020–2027 (USD MILLION)96
9LEGIONELLA TESTING MARKET, BY REGION97
9.1INTRODUCTION98
TABLE 44LEGIONELLA TESTING MARKET, BY REGION, 2020–2027 (USD MILLION)98
9.2NORTH AMERICA98
FIGURE 27NORTH AMERICA: LEGIONELLA TESTING MARKET SNAPSHOT99
TABLE 45NORTH AMERICA: LEGIONELLA TESTING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)99
TABLE 46NORTH AMERICA: LEGIONELLA TESTING MARKET, BY TEST TYPE, 2020–2027 (USD MILLION)100
TABLE 47NORTH AMERICA: LEGIONELLA TESTING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)100
TABLE 48NORTH AMERICA: LEGIONELLA TESTING MARKET, BY END USER, 2020–2027 (USD MILLION)100
9.2.1US101
9.2.1.1Strong presence of major market players to drive growth101
TABLE 49US: LEGIONELLA TESTING MARKET, BY TEST TYPE, 2020–2027 (USD MILLION)101
TABLE 50US: LEGIONELLA TESTING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)101
TABLE 51US: LEGIONELLA TESTING MARKET FOR WATER TESTING, BY TYPE, 2020–2027 (USD MILLION)102
TABLE 52US: LEGIONELLA TESTING MARKET FOR IVD TESTING, BY TYPE, 2020–2027 (USD MILLION)102
TABLE 53US: LEGIONELLA TESTING MARKET, BY END USER, 2020–2027 (USD MILLION)102
9.2.2CANADA103
9.2.2.1Rising incidence of lifestyle diseases to drive market growth103
TABLE 54CANADA: LEGIONELLA TESTING MARKET, BY TEST TYPE, 2020–2027 (USD MILLION)103
TABLE 55CANADA: LEGIONELLA TESTING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)103
TABLE 56CANADA: LEGIONELLA TESTING MARKET FOR WATER TESTING, BY TYPE, 2020–2027 (USD MILLION)104
TABLE 57CANADA: LEGIONELLA TESTING MARKET FOR IVD TESTING, BY TYPE, 2020–2027 (USD MILLION)104
TABLE 58CANADA: LEGIONELLA TESTING MARKET, BY END USER, 2020–2027 (USD MILLION)104
9.3EUROPE105
TABLE 59EUROPE: LEGIONELLA TESTING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)105
TABLE 60EUROPE: LEGIONELLA TESTING MARKET, BY TEST TYPE, 2020–2027 (USD MILLION)106
TABLE 61EUROPE: LEGIONELLA TESTING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)106
TABLE 62EUROPE: LEGIONELLA TESTING MARKET, BY END USER, 2020–2027 (USD MILLION)106
9.3.1GERMANY107
9.3.1.1Germany dominates Legionella testing market in Europe107
TABLE 63GERMANY: LEGIONELLA TESTING MARKET, BY TEST TYPE, 2020–2027 (USD MILLION)107
TABLE 64GERMANY: LEGIONELLA TESTING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)107
TABLE 65GERMANY: LEGIONELLA TESTING MARKET FOR WATER TESTING, BY TYPE, 2020–2027 (USD MILLION)108
TABLE 66GERMANY: LEGIONELLA TESTING MARKET FOR IVD TESTING, BY TYPE, 2020–2027 (USD MILLION)108
TABLE 67GERMANY: LEGIONELLA TESTING MARKET, BY END USER, 2020–2027 (USD MILLION)108
9.3.2UK109
9.3.2.1Growing number of accredited diagnostic laboratories to propel market growth109
TABLE 68UK: LEGIONELLA TESTING MARKET, BY TEST TYPE, 2020–2027 (USD MILLION)109
TABLE 69UK: LEGIONELLA TESTING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)110
TABLE 70UK: LEGIONELLA TESTING MARKET FOR WATER TESTING, BY TYPE, 2020–2027 (USD MILLION)110
TABLE 71UK: LEGIONELLA TESTING MARKET FOR IVD TESTING, BY TYPE, 2020–2027 (USD MILLION)110
TABLE 72UK: LEGIONELLA TESTING MARKET, BY END USER, 2020–2027 (USD MILLION)111
9.3.3FRANCE111
9.3.3.1Rising R&D expenditure and increasing demand for early diagnosis to drive market growth111
TABLE 73FRANCE: LEGIONELLA TESTING MARKET, BY TEST TYPE, 2020–2027 (USD MILLION)111
TABLE 74FRANCE: LEGIONELLA TESTING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)112
TABLE 75FRANCE: LEGIONELLA TESTING MARKET FOR WATER TESTING, BY TYPE, 2020–2027 (USD MILLION)112
TABLE 76FRANCE: LEGIONELLA TESTING MARKET FOR IVD TESTING, BY TYPE, 2020–2027 (USD MILLION)112
TABLE 77FRANCE: LEGIONELLA TESTING MARKET, BY END USER, 2020–2027 (USD MILLION)113
9.3.4ITALY113
9.3.4.1Adoption of advanced diagnostic technologies to drive market growth113
TABLE 78ITALY: LEGIONELLA TESTING MARKET, BY TEST TYPE, 2020–2027 (USD MILLION)114
TABLE 79ITALY: LEGIONELLA TESTING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)114
TABLE 80ITALY: LEGIONELLA TESTING MARKET FOR WATER TESTING, BY TYPE, 2020–2027 (USD MILLION)114
TABLE 81ITALY: LEGIONELLA TESTING MARKET FOR IVD TESTING, BY TYPE, 2020–2027 (USD MILLION)115
TABLE 82ITALY: LEGIONELLA TESTING MARKET, BY END USER, 2020–2027 (USD MILLION)115
9.3.5SPAIN115
9.3.5.1Rising geriatric population to drive market growth115
TABLE 83SPAIN: LEGIONELLA TESTING MARKET, BY TEST TYPE, 2020–2027 (USD MILLION)116
TABLE 84SPAIN: LEGIONELLA TESTING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)116
TABLE 85SPAIN: LEGIONELLA TESTING MARKET FOR WATER TESTING, BY TYPE, 2020–2027 (USD MILLION)117
TABLE 86SPAIN: LEGIONELLA TESTING MARKET FOR IVD TESTING, BY TYPE, 2020–2027 (USD MILLION)117
TABLE 87SPAIN: LEGIONELLA TESTING MARKET, BY END USER, 2020–2027 (USD MILLION)117
9.3.6REST OF EUROPE118
TABLE 88ROE: LEGIONELLA TESTING MARKET, BY TEST TYPE, 2020–2027 (USD MILLION)118
TABLE 89ROE: LEGIONELLA TESTING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)119
TABLE 90ROE: LEGIONELLA TESTING MARKET FOR WATER TESTING, BY TYPE, 2020–2027 (USD MILLION)119
TABLE 91ROE: LEGIONELLA TESTING MARKET FOR IVD TESTING, BY TYPE, 2020–2027 (USD MILLION)119
TABLE 92ROE: LEGIONELLA TESTING MARKET, BY END USER, 2020–2027 (USD MILLION)120
9.4ASIA PACIFIC120
FIGURE 28APAC: LEGIONELLA TESTING MARKET SNAPSHOT121
TABLE 93ASIA PACIFIC: LEGIONELLA TESTING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)122
TABLE 94ASIA PACIFIC: LEGIONELLA TESTING MARKET, BY TEST TYPE, 2020–2027 (USD MILLION)122
TABLE 95ASIA PACIFIC: LEGIONELLA TESTING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)122
TABLE 96ASIA PACIFIC: LEGIONELLA TESTING MARKET, BY END USER, 2020–2027 (USD MILLION)123
9.4.1CHINA123
9.4.1.1Growing public access to modern healthcare to drive market growth123
TABLE 97CHINA: LEGIONELLA TESTING MARKET, BY TEST TYPE, 2020–2027 (USD MILLION)124
TABLE 98CHINA: LEGIONELLA TESTING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)124
TABLE 99CHINA: LEGIONELLA TESTING MARKET FOR WATER TESTING, BY TYPE, 2020–2027 (USD MILLION)124
TABLE 100CHINA: LEGIONELLA TESTING MARKET FOR IVD TESTING, BY TYPE, 2020–2027 (USD MILLION)125
TABLE 101CHINA: LEGIONELLA TESTING MARKET, BY END USER, 2020–2027 (USD MILLION)125
9.4.2JAPAN125
9.4.2.1Universal healthcare reimbursement policy to drive market growth125
TABLE 102JAPAN: LEGIONELLA TESTING MARKET, BY TEST TYPE, 2020–2027 (USD MILLION)126
TABLE 103JAPAN: LEGIONELLA TESTING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)126
TABLE 104JAPAN: LEGIONELLA TESTING MARKET FOR WATER TESTING, BY TYPE, 2020–2027 (USD MILLION)127
TABLE 105JAPAN: LEGIONELLA TESTING MARKET FOR IVD TESTING, BY TYPE, 2020–2027 (USD MILLION)127
TABLE 106JAPAN: LEGIONELLA TESTING MARKET, BY END USER, 2020–2027 (USD MILLION)127
9.4.3INDIA128
9.4.3.1Increasing private & public investments in healthcare to drive market growth128
TABLE 107INDIA: LEGIONELLA TESTING MARKET, BY TEST TYPE, 2020–2027 (USD MILLION)128
TABLE 108INDIA: LEGIONELLA TESTING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)129
TABLE 109INDIA: LEGIONELLA TESTING MARKET FOR WATER TESTING, BY TYPE, 2020–2027 (USD MILLION)129
TABLE 110INDIA: LEGIONELLA TESTING MARKET FOR IVD TESTING, BY TYPE, 2020–2027 (USD MILLION)129
TABLE 111INDIA: LEGIONELLA TESTING MARKET, BY END USER, 2020–2027 (USD MILLION)130
9.4.4REST OF ASIA PACIFIC130
TABLE 112ROAPAC: LEGIONELLA TESTING MARKET, BY TEST TYPE, 2020–2027 (USD MILLION)131
TABLE 113ROAPAC: LEGIONELLA TESTING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)131
TABLE 114ROAPAC: LEGIONELLA TESTING MARKET FOR WATER TESTING, BY TYPE, 2020–2027 (USD MILLION)131
TABLE 115ROAPAC: LEGIONELLA TESTING MARKET FOR IVD TESTING, BY TYPE, 2020–2027 (USD MILLION)132
TABLE 116ROAPAC: LEGIONELLA TESTING MARKET, BY END USER, 2020–2027 (USD MILLION)132
9.5LATIN AMERICA132
9.5.1RISING HEALTHCARE EXPENDITURE TO DRAW FOREIGN PLAYERS132
TABLE 117LATIN AMERICA: LEGIONELLA TESTING MARKET, BY TEST TYPE, 2020–2027 (USD MILLION)133
TABLE 118LATIN AMERICA: LEGIONELLA TESTING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)133
TABLE 119LATIN AMERICA: LEGIONELLA TESTING MARKET, BY END USER, 2020–2027 (USD MILLION)134
9.6MIDDLE EAST & AFRICA134
9.6.1RISING ACCESS TO ADVANCED TECHNOLOGIES AND GROWING INVESTMENTS TO SUPPORT MARKET GROWTH134
TABLE 120MIDDLE EAST & AFRICA: LEGIONELLA TESTING MARKET, BY TEST TYPE, 2020–2027 (USD MILLION)135
TABLE 121MIDDLE EAST & AFRICA: LEGIONELLA TESTING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)135
TABLE 122MIDDLE EAST & AFRICA: LEGIONELLA TESTING MARKET, BY END USER, 2020–2027 (USD MILLION)135
10COMPETITIVE LANDSCAPE136
10.1OVERVIEW136
10.2KEY PLAYER STRATEGIES/RIGHT TO WIN136
10.2.1OVERVIEW OF STRATEGIES DEPLOYED BY PLAYERS IN THE LEGIONELLA TESTING MARKET136
TABLE 123STRATEGIC DEVELOPMENTS REPORTED136
10.3REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS137
FIGURE 29REVENUE SHARE ANALYSIS OF TOP PLAYERS137
10.4MARKET SHARE ANALYSIS138
10.4.1LEGIONELLA TESTING MARKET138
FIGURE 30LEGIONELLA TESTING MARKET SHARE, BY KEY PLAYER (2021)138
TABLE 124LEGIONELLA TESTING MARKET: DEGREE OF COMPETITION139
10.5COMPANY EVALUATION MATRIX140
10.5.1LIST OF EVALUATED VENDORS140
10.5.2STARS140
10.5.3EMERGING LEADERS140
10.5.4PERVASIVE PLAYERS140
10.5.5PARTICIPANTS140
FIGURE 31LEGIONELLA TESTING MARKET: COMPETITIVE LEADERSHIP MAPPING, 2021141
10.6COMPETITIVE LEADERSHIP MAPPING FOR START-UPS/SMES (2021)142
10.6.1PROGRESSIVE COMPANIES142
10.6.2STARTING BLOCKS142
10.6.3RESPONSIVE COMPANIES142
10.6.4DYNAMIC COMPANIES142
FIGURE 32LEGIONELLA TESTING MARKET: COMPETITIVE LEADERSHIP MAPPING FOR START-UPS/SMES, 2021143
10.7COMPETITIVE BENCHMARKING144
10.7.1PRODUCT AND REGIONAL FOOTPRINT ANALYSIS144
FIGURE 33PRODUCT AND REGIONAL FOOTPRINT ANALYSIS OF TOP PLAYERS IN LEGIONELLA TESTING MARKET144
TABLE 125LEGIONELLA TESTING MARKET: COMPETITIVE BENCHMARKING OF KEY PLAYERS144
TABLE 126PRODUCT FOOTPRINT ANALYSIS OF KEY PLAYERS145
TABLE 127REGIONAL FOOTPRINT ANALYSIS OF KEY PLAYERS145
TABLE 128LEGIONELLA TESTING MARKET: DETAILED LIST OF KEY START-UPS/SMES145
10.8COMPETITIVE SCENARIO146
10.8.1PRODUCT LAUNCHES146
TABLE 129LEGIONELLA TESTING MARKET: KEY PRODUCT LAUNCHES & REGULATORY APPROVALS146
10.8.2DEALS146
TABLE 130LEGIONELLA TESTING MARKET: KEY DEALS146
10.8.3OTHER DEVELOPMENTS147
TABLE 131LEGIONELLA TESTING MARKET: OTHER DEVELOPMENTS147
11COMPANY PROFILES148
(Business Overview, Products Offered, Recent Developments, MnM View SWOT analysis) *
11.1KEY PLAYERS148
11.1.1INDUSTRIAL/WATER148
11.1.1.1Thermo Fisher Scientific148
TABLE 132THERMO FISHER SCIENTIFIC: BUSINESS OVERVIEW148
FIGURE 34THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2021)149
11.1.1.2Merck KGAA152
TABLE 133MERCK KGAA: BUSINESS OVERVIEW152
FIGURE 35MERCK KGAA: COMPANY SNAPSHOT (2021)153
11.1.1.3Bio-Rad Laboratories156
TABLE 134BIO-RAD LABORATORIES: BUSINESS OVERVIEW156
FIGURE 36BIO-RAD LABORATORIES: COMPANY SNAPSHOT (2021)157
11.1.1.4IDEXX Laboratories159
TABLE 135IDEXX LABORATORIES: BUSINESS OVERVIEW159
FIGURE 37IDEXX LABORATORIES: COMPANY SNAPSHOT (2021)160
11.1.1.5Biomérieux SA162
TABLE 136BIOMÉRIEUX SA: BUSINESS OVERVIEW162
FIGURE 38BIOMÉRIEUX SA: COMPANY SNAPSHOT (2021)163
11.1.1.6Becton, Dickinson and Company165
TABLE 137BECTON, DICKINSON, AND COMPANY: BUSINESS OVERVIEW165
FIGURE 39BECTON, DICKINSON, AND COMPANY: COMPANY SNAPSHOT (2021)166
11.1.1.7Eurofins Scientific168
TABLE 138EUROFINS SCIENTIFIC: BUSINESS OVERVIEW168
FIGURE 40EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2021)168
11.1.1.8Takara Bio171
TABLE 139TAKARA BIO: BUSINESS OVERVIEW171
FIGURE 41TAKARA BIO: COMPANY SNAPSHOT (2021)172
11.1.1.9Eiken Chemical174
TABLE 140EIKEN CHEMICAL: BUSINESS OVERVIEW174
FIGURE 42EIKEN CHEMICAL: COMPANY SNAPSHOT (2021)174
11.1.1.10Qiagen176
TABLE 141QIAGEN: BUSINESS OVERVIEW176
FIGURE 43QIAGEN: COMPANY SNAPSHOT (2021)177
11.1.1.11Genomadix179
TABLE 142GENOMADIX, INC.: BUSINESS OVERVIEW179
11.2OTHER PLAYERS180
11.2.1INDUSTRIAL/WATER180
11.2.1.1Pall Corporation (DANAHER)180
11.2.1.2Phigenics, Llc181
11.2.1.3Environmental safety technologies182
11.2.1.4Hydrosense182
11.2.1.5Accepta183
11.2.1.6Luminultra technologies183
11.2.1.7Bioalert solutions184
11.2.1.8Aquacert184
11.2.1.9Pacific water technology185
11.2.1.10DTK Water186
11.2.1.11Sens solutions186
11.2.2HEALTHCARE187
11.2.2.1Alere (ABBOTT)187
TABLE 143ABBOTT: BUSINESS OVERVIEW187
FIGURE 44ABBOTT: COMPANY SNAPSHOT (2021)188
11.2.2.2Roche Diagnostics190
TABLE 144ROCHE DIAGNOSTICS: BUSINESS OVERVIEW190
FIGURE 45ROCHE DIAGNOSTICS: COMPANY SNAPSHOT (2021)191
11.2.2.3Hologic194
TABLE 145HOLOGIC: BUSINESS OVERVIEW194
FIGURE 46HOLOGIC: COMPANY SNAPSHOT (2021)195
11.2.2.4Quidel Corporation198
TABLE 146QUIDEL CORPORATION: BUSINESS OVERVIEW198
FIGURE 47QUIDEL CORPORATION: COMPANY SNAPSHOT (2021)199
11.2.2.5Pro-Lab Diagnostics200
*Details on Business Overview, Products Offered, Recent Developments, MnM View, SWOT analysis might not be captured in case of unlisted companies.
12APPENDIX201
12.1DISCUSSION GUIDE201
12.2KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL205
12.3CUSTOMIZATION OPTIONS207
12.4RELATED REPORTS207
12.5AUTHOR DETAILS208

Report Title: Legionella Testing Market by Test Type (Culture, Urinary Antigen Test, DFA, PCR), Application (Water & IVD Testing (Urine, Blood)), End User (Hospitals, Clinics, Diagnostic Labs, Water Treatment Industries), Region - Global Forecast to 2027


Your Details
Valid Invalid number

SELECT A FORMAT

ADD TO CART BUY NOW

Related Report

2023 What's Next for Vietnam Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2023 What's Next for Vietnam Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2023 What's Next for Venezuela Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2023 What's Next for Venezuela Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2023 What's Next for US Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2023 What's Next for US Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2023 What's Next for Uruguay Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2023 What's Next for Uruguay Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2023 What's Next for United Arab Emirates Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2023 What's Next for United Arab Emirates Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2023 What's Next for Ukraine Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2023 What's Next for Ukraine Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM